Treatment‐related adverse events of antibody‐drug conjugates in clinical trials: A systematic review and meta‐analysisJinming Li, Jiuda Zhao, Guoshuang Shen et al.|Cancer Innovation|2023Cited by 15
Population Pharmacokinetics and Exposure‐Response Relationship of Zimberelimab in Chinese Patients with Advanced TumorsFang Yang, Jiman Zhu, Yongying Lu et al.|Clinical Pharmacology in Drug Development|2024Cited by 0
Urinary 8-oxoGuo as a potential novel evaluation biomarker for patients with systemic lupus erythematosusJingjing Wang, Peiming Zheng, Zhaoqiang Jiang et al.|Clinical and Experimental Medicine|2025Cited by 0